Vivani Medical VANI
NASDAQ VANI
$1.38 -0.03 (-2.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Vivani Medical (VANI) Accumulated Expenses (2014 - 2026)

Vivani Medical (VANI) posted quarterly Accumulated Expenses of $1.7 million for Q1 2026, up 378.57% year-over-year from $350000.0 in Q1 2025, and up 358.9% quarter-over-quarter from $365000.0 in Q4 2025.

Vivani Medical (VANI) Accumulated Expenses (2014 - 2026) Analysis & Trends

Vivani Medical's Accumulated Expenses history runs 13 years deep, the most recent figure standing at $1.7 million for Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 378.57% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 378.57% YoY), while the FY2025 annual figure was $365000.0, down 78.21% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $1.7 million, up from $365000.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $2.4 million in Q4 2022, with the low at $350000.0 in Q1 2025.
  • The 5-year median for Accumulated Expenses is $676000.0 (2023), against an average of $1.0 million.
  • The sharpest annual moves came in 2023 and 2026: Accumulated Expenses tumbled 83.21% in 2023, then jumped 378.57% in 2026.
  • Vivani Medical's Accumulated Expenses stood at $2.4 million in 2022, then sank by 83.21% to $396000.0 in 2023, then jumped by 322.98% to $1.7 million in 2024, then slumped by 78.21% to $365000.0 in 2025, then surged by 358.9% to $1.7 million in 2026.
  • Business Quant data shows VANI's Accumulated Expenses at $1.7 million in Q1 2026, $365000.0 in Q4 2025, and $2.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Vivani Medical 120.18 Mn 100.29 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 1.68 Mn
Mar 31, 2026 1.68 Mn
Dec 31, 2025 365,000.00
Sep 30, 2025 1.98 Mn
Jun 30, 2025 356,000.00
Mar 31, 2025 350,000.00
Dec 31, 2024 1.68 Mn
Sep 30, 2024 1.68 Mn
Jun 30, 2024 384,000.00
Mar 31, 2024 1.68 Mn
Dec 31, 2023 396,000.00
Sep 30, 2023 676,000.00
Jun 30, 2023 567,000.00
Mar 31, 2023 415,000.00
Dec 31, 2022 2.36 Mn
Sep 30, 2022 1.85 Mn
Jun 30, 2022 796,000.00
Mar 31, 2022 462,000.00
Dec 31, 2021 895,000.00
Sep 30, 2021 575,000.00